Angina Market Intelligence, Research

Angina pectoris is basically a chest pain or discomfort caused due to coronary heart disease. The angina pectoris occurs when the heart muscle does not receive enough oxygen or when one or more of the heart's arteries is narrowed or blocked, a condition known as ischemia. They are cured using various drugs such as beta blockers, nitrates and calcium channel blockers, angiotensin-converting enzyme inhibitors and others.

The development of biosimilars and biobetters, increase in diabetic and hypertension population due to bad lifestyle and increase in consumption of alcohol and smoking are the significant factors responsible for driving the growth of the angina market in the above-mentioned forecast period. Additionally, the growing investments and spending by consumers in healthcare along with the rising prevalence and incidence of angina pectoris also heighten the overall growth of the market. However, the downward pricing pressure owing to its commodity nature obstruct the market’s growth. The high cost for surgical procedures like coronary bypass surgery is expected to hamper the overall growth of the market.